Zepbound Vials: The Business Case - Listen - On The Pen: The

Zepbound Vials: The Business Case

Listen now

Description

Send us a Text Message.Dave Knapp makes the business case for why Eli Lilly won’t simply release the vials - they have to.Email Alerts: https://www.onthepen.com/emailsBECOME A MEMBER HERE TO WATCH THE VIDEO:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinBloomberg #ReleaseTheVials Feature:https://www.bloomberg.com/news/articles/2024-04-02/zepbound-shortage-patients-push-eli-lilly-to-release-more-obesity-drug-supplyYahoo Finanace #ReleaseTheVials Feature VIDEO: https://youtu.be/nQ...

More Episodes

See all »

Novo Nordisk's War on Compound Semaglutide, Maritide Has Some Negative News

Send us a textIn this episode of On The Pen: The Weekly Dose, host Dave Knapp dives into the latest updates in obesity medicine, with insightful takes on current treatment breakthroughs, new medication approvals, and tips on navigating healthcare options. This week’s deep dive also touches on...

Published 11/12/24

Viking Therapeutics and AstraZeneca Steal The Show at Obesity Week!

Send us a textSemaglutide News: https://www.onthepen.com/post/select-trial-update-semaglutide-s-cardiovascular-benefits-and-psychiatric-safety-profile-highlighteViking Therapeutics News:https://www.onthepen.com/post/vk2735-vikingtideAstraZeneca News:...

Published 11/05/24

On The Pen With Dave Knapp

Published 11/05/24